Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

MNKD
Mannkind Corporation
stock NASDAQ

At Close
Sep 25, 2025 3:59:58 PM EDT
5.33USD0.000%(0.00)4,610,122
5.33Bid   5.34Ask   0.01Spread
Pre-market
Sep 25, 2025 9:27:30 AM EDT
5.35USD+0.375%(+0.02)11,111
After-hours
Sep 25, 2025 4:43:30 PM EDT
5.33USD0.000%(0.00)20,785
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 5, 2022
06:10AM EST  MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer Michael Castagna, PharmD, will present at the H.C. Wainwright Bioconnect Conference which will be available on demand starting on January 10, 2022.   GlobeNewswire Inc
06:08AM EST  MannKind Extends Collaboration With Thirona Bio On Fibrotic Lung Diseases Through Purchase Of Additional Convertible Note Issued By Thirona   Benzinga
06:05AM EST  -- MannKind purchased an additional convertible note issued by Thirona Bio -- Nonclinical PD study of MNKD-501 planned, with results anticipated in 2Q 2022 -- MannKinds CEO appointed as a member of the Thirona board of directors   GlobeNewswire Inc
Dec 6, 2021
06:05AM EST  MannKind Corporation to Participate in the Lytham Partners Winter   GlobeNewswire Inc
Nov 30, 2021
04:44PM EST  MannKind Corporation Granted U.S. Patent #11,185,645 'Dry powder inhaler and system for drug delivery'   Benzinga
Nov 9, 2021
06:02PM EST  MannKind Q3 EPS $(0.04) Beats $(0.07) Estimate, Sales $22.21M Beat $19.88M Estimate   Benzinga
05:04PM EST  Recap: MannKind Q3 Earnings   Benzinga
11:42AM EST  The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data   Benzinga
11:26AM EST  Mannkind Corporation Closed Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds   Benzinga
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
06:05AM EST  Mannkind Corporation Closes Sale-Leaseback Transaction Generating   GlobeNewswire Inc
Nov 5, 2021
01:24PM EDT  Wall Street Crime and Punishment: Martin Shkreli, The Self-Destructive Pharma Bro   Benzinga
07:05AM EDT  -- A Technosphere Insulin (TI) dose approximately double the estimated mealtime subcutaneously (SC) injection dose reduced postprandial glucose excursions (PPGE) without any severe hypoglycemia in the first two hours -- Higher dose of TI resulted in approximately 50 mg/dL improvement in PPGE at 120 minutes   GlobeNewswire Inc
Nov 2, 2021
06:05AM EDT  MannKind Corporation (Nasdaq:MNKD) will release its 2021 third quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Tuesday, November 9, 2021.   GlobeNewswire Inc
Oct 19, 2021
06:20AM EDT  Mankind Pharma Received FDA REMS Approval for ALOSETRON HYDROCHLORIDE Under ANDA #213614   Benzinga
Oct 18, 2021
02:37PM EDT  Mid-Afternoon Market Update: Dow Falls 70 Points; Evolving Systems Shares Spike Higher   Benzinga
12:56PM EDT  Mid-Day Market Update: Nasdaq Rises 50 Points; Revance Therapeutics Shares Plummet   Benzinga
09:20AM EDT  Why MannKind Shares Are Falling Today   Benzinga
06:06AM EDT  United Therapeutics Provides An Update On The Progress Of The Tyvaso DPI New Drug Application   Benzinga
06:00AM EDT  -- Complete response received by United Therapeutics cites an open inspection issue at a third-party analytical testing center; no other deficiencies cited -- No issues identified regarding operations performed at MannKinds manufacturing facility in Connecticut   GlobeNewswire Inc
Oct 4, 2021
07:11AM EDT  MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza In Pediatric Population   Benzinga
07:07AM EDT  MannKind Enrolls First Patient Enrolled In Inhale-1 Study Of Afrezza In Pediatric Population   RTTNews
07:05AM EDT  MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza(r) In   PR Newswire
07:05AM EDT  MannKind Announces First Patient Enrolled in INHALE-1 Study of   GlobeNewswire Inc
Oct 1, 2021
02:29PM EDT  Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates   Benzinga
Sep 30, 2021
07:43AM EDT  The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug   Benzinga
Sep 29, 2021
04:25PM EDT  Mannkind Corporation Announces Sale-Leaseback Transaction Generating $102.25M In Non-Dilutive Gross Proceeds   Benzinga
04:24PM EDT  MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that it has entered into a sale-leaseback transaction with an affiliate of Creative Manufacturing Properties, which will generate $102.25 million in gross proceeds upon closing.   GlobeNewswire Inc
Sep 28, 2021
06:05AM EDT  MannKind Corporation to Participate at Lytham Partners Fall 2021   GlobeNewswire Inc
Sep 22, 2021
02:12PM EDT  MannKind Option Alert: Jan, 2023 $10 Calls at the Ask: 456 @ $0.55 vs 4558 OI; Earnings 11/3 After Close [est] Ref=$4.6701   Benzinga
12:58PM EDT  MannKind's Return On Capital Employed Overview   Benzinga
Sep 15, 2021
06:05AM EDT  MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that it will be participating at upcoming conferences. Presenting from the Company will be its Chief Executive Officer, Michael Castagna, PharmD.   GlobeNewswire Inc
Sep 7, 2021
09:54AM EDT  United Therapeutics-MannKind's Formulated Tyvaso Shows Benefit In Pulmonary Hypertension Patients   Benzinga
06:05AM EDT  MannKind Corporation to Participate in H.C. Wainwright 23rd Annual   GlobeNewswire Inc
06:03AM EDT  United Therapeutics Presents Tyvaso DPI BREEZE Clinical Data At European Respiratory Society International Congress 2021   RTTNews
06:01AM EDT  United Therapeutics Presents Tyvaso DPI(tm) BREEZE Clinical Data At The   PR Newswire
Aug 12, 2021
09:57AM EDT  MannKind Files For U.S. Patent Application Titled 'DRY POWDER DRUG DELIVERY SYSTEM'   Benzinga
09:56AM EDT  MannKind Files For U.S. Patent Application Titled 'Use of Ultrarapid Acting Insulin'   Benzinga
09:56AM EDT  MannKind Files For U.S. Patent Application Titled 'HEAT-STABLE DRY POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS'   Benzinga
Aug 11, 2021
04:23PM EDT  MannKind: Q2 Earnings Insights   Benzinga
04:01PM EDT  MannKind Q2 EPS $(0.05) Misses $(0.04) Estimate, Sales $23.30M Beat $17.49M Estimate   Benzinga
04:00PM EDT  MannKind Corporation Reports 2021 Second Quarter Financial Results   GlobeNewswire Inc
09:06AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
08:14AM EDT  The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering   Benzinga
04:27AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
08:26AM EDT  MannKind's Debt Overview   Benzinga
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
07:50AM EDT  MannKind Corp. (MNKD) said it has partnered with NRx Pharmaceuticals (NRXP) to evaluate the feasibility of formulating a dry powder formulation of ZYESAMI or aviptadil, a synthetic form of human Vasoactive Intestinal Peptide - an endogenous substance produced by the body that helps protect cells against inflammatory conditions.   RTTNews
06:54AM EDT  MannKind Partners With NRx Pharm To Explore Dry Powder Formulation Of ZYESAMI Based On Technosphere Platform   RTTNews
06:50AM EDT  MannKind Corporation And NRx Pharmaceuticals To Evaluate Feasibility Of Formulating A Dry Powder Formulation Of ZYESAMI   Benzinga
06:48AM EDT  MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation   PR Newswire
06:48AM EDT  NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI(tm)   PR Newswire
06:15AM EDT  MannKind Corporation (Nasdaq:MNKD) will release its 2021 second quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, August 11, 2021.   GlobeNewswire Inc
Aug 3, 2021
09:40AM EDT  MannKind Corporation Granted U.S. Patent Titled 'Apparatus and method for cryogranulating a pharmaceutical composition'   Benzinga
09:00AM EDT  MannKind Corporation to Participate in the BTIG Virtual   GlobeNewswire Inc
Jul 29, 2021
11:01AM EDT  INDYCAR Driver Conor Daly To Share His Personal Diabetes Story And Race   PR Newswire
Jul 23, 2021
09:37AM EDT  Mannkind Sponsored Study Titled 'Afrezza INHALE-1 Study in Pediatrics (INHALE-1)' Published To ClinicalTrials.Gov, Study Not Yet Recruiting   Benzinga
Jun 29, 2021
08:25AM EDT  Watching Insulin Manufacturers After Walmart Announces Private Brand Analog Insulin   Benzinga
Jun 28, 2021
07:50AM EDT  Cramer Gives His Opinion On Carlotz, MannKind And More   Benzinga
06:16AM EDT  Policy Change Allows Approval For Medicare Patients Living With Diabetes To Use Both Afrezza And Continuous Glucose Monitoring Devices Beginning July 18   Benzinga
06:15AM EDT  Policy Change Allows Approval For Medicare Patients Living With Diabetes To Use   PR Newswire
Jun 25, 2021
11:38AM EDT  MannKind Presents Two Posters At American Diabetes Association's Virtual 81st Scientific Sessions, June 25-29   Benzinga
11:35AM EDT  MannKind Presents Two Posters At American Diabetes Association's Virtual 81st   PR Newswire
Jun 16, 2021
12:13PM EDT  MannKind Says FDA Grants Priority Review For Tyvaso DPI NDA   RTTNews
11:03AM EDT  MannKind : FDA Accepts For Priority Review Of NDA For Tyvaso DPI For Treatment Of PAH And PH-ILD   RTTNews
11:00AM EDT  MannKind And United Therapeutics Achieve A Major Milestone In The Development   PR Newswire
07:26AM EDT  MannKind - United Therapeutics' Formulated Treprostinil Under FDA Review For Pulmonary Hypertension   Benzinga
06:15AM EDT  -- Tyvaso DPI includes the second compound formulated with MannKinds Technosphere technology to be reviewed by the FDA -- FDA review expected to be complete in October 2021 -- Hiring expansion underway at MannKinds manufacturing facility in Connecticut   GlobeNewswire Inc
06:08AM EDT  United Therapeutics Announces FDA Acceptance Of Tyvaso DPI New Drug Application For Priority Review   Benzinga
06:01AM EDT  United Therapeutics Announces FDA Acceptance of Tyvaso DPI(tm) New Drug   PR Newswire
Jun 10, 2021
08:13AM EDT  The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal   Benzinga
06:17AM EDT  MannKind and Thirona Bio Join Forces to Evaluate Potential Inhaled Therapy for Fibrotic Lung Diseases   Benzinga
06:15AM EDT  MannKind will conduct formulation and preclinical studiesof a new chemical entity owned by Thirona   GlobeNewswire Inc
Jun 8, 2021
05:00PM EDT  MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will present at the Lytham Partners Summer 2021 Investor Conference on Monday, June 14, 2021 at 11:45 AM (ET).   GlobeNewswire Inc
Jun 3, 2021
06:04AM EDT  MannKind Presents A Post Hoc Analysis From STAT Study   RTTNews
06:01AM EDT  Advanced Technologies & Treatments For Diabetes (ATTD 2021) To Be Held Virtually June 2-5   PR Newswire
May 26, 2021
08:57AM EDT  ROCE Insights For MannKind   Benzinga
May 20, 2021
09:03AM EDT  INDYCAR Driver Conor Daly To Share His Personal Diabetes Story And Race   PR Newswire
May 14, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 14, 2021   Benzinga
06:29AM EDT  RBC Capital Initiates Coverage On MannKind with Sector Perform Rating, Announces Price Target of $5   Benzinga
May 13, 2021
09:12AM EDT  MannKind Announces Partnership With Type 1 Diabetes IndyCar Driver Conor Daly   Benzinga
09:00AM EDT  Daly to drive bold Tired of Pricks? design for Ed Carpenter Racingat GMR Grand Prix on May 15 at Indianapolis Motor Speedway   GlobeNewswire Inc
May 12, 2021
04:59PM EDT  MannKind: Q1 Earnings Insights   Benzinga
04:02PM EDT  MannKind Q1 EPS $(0.05) Misses $(0.04) Estimate, Sales $17.44M Beat $15.66M Estimate   Benzinga
04:00PM EDT  MannKind Corporation Reports 2021 First Quarter Financial Results   GlobeNewswire Inc
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
04:22AM EDT  Earnings Scheduled For May 12, 2021   Benzinga
May 11, 2021
10:16AM EDT  A Preview Of MannKind's Earnings   Benzinga
09:00AM EDT  MannKind Corporation to Participate in 2021 RBC Capital Markets   GlobeNewswire Inc
May 5, 2021
09:00AM EDT  MannKind Corporation (Nasdaq:MNKD) will release its 2021 first quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, May 12, 2021.   GlobeNewswire Inc
Apr 26, 2021
09:02AM EDT  MannKind Reduces Legacy Debt by Approximately $49.5M   Benzinga
09:00AM EDT  MannKind Reduces Legacy Debt by Approximately $49.5 Million and   GlobeNewswire Inc
Apr 19, 2021
09:00AM EDT  Clinicaltrials.gov Shows 'Dosing Optimization Study' for Mannkind's Afrezza   Benzinga
08:55AM EDT  Clinicaltrials.gov Shows Dosing Optimization Study for Mannkind's Afrezza   Benzinga
07:11AM EDT  MannKind Corporation (MNKD) and United Therapeutics (UTHR) today said United Therapeutics has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for its Tyvaso DPI.   RTTNews
06:09AM EDT  MannKind, United Therapeutics Reach Milestone In Development Of Tyvaso DPI   RTTNews
06:01AM EDT  Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI With New Drug Application Submitted to the FDA   Benzinga
06:00AM EDT  MannKind Corporation (Nasdaq: MNKD) and United Therapeutics (Nasdaq: UTHR) reached a milestone today in the development of Tyvaso DPI as United Therapeutics submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA).   GlobeNewswire Inc
Mar 16, 2021
09:00AM EDT  MannKind Announces Closing of Initial Purchasers   GlobeNewswire Inc
Mar 15, 2021
08:00AM EDT  MannKind to Participate in 2022 Medicare Part D Senior Savings   GlobeNewswire Inc
Mar 10, 2021
05:00PM EST  MannKind Corporation to Participate in Oppenheimer's 31st Annual   GlobeNewswire Inc
Mar 5, 2021
07:28AM EST  SVB Leerink Maintains Outperform on MannKind, Raises Price Target to $5   Benzinga
Mar 2, 2021
05:00PM EST  MannKind Corporation to Participate in H.C. Wainwright Global Life   GlobeNewswire Inc
06:36AM EST  MannKind Prices Upsized $200.0 Mln Convertible Senior Notes Offering   RTTNews
06:30AM EST  MannKind Corporation Prices Upsized $200.0 Million Convertible   GlobeNewswire Inc
Mar 1, 2021
07:00AM EST  MannKind Corporation Announces Proposed Private Placement of   GlobeNewswire Inc
Feb 26, 2021
10:05AM EST  What Does MannKind's Debt Look Like?   Benzinga
Feb 25, 2021
08:24AM EST  MannKind Corp. Posts Adj. Loss In Q4   RTTNews
08:10AM EST  MannKind Q4 Loss/Shr $0.11 Vs Loss $0.07 Last Year   RTTNews
08:08AM EST  The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants   Benzinga
08:04AM EST  MannKind Q4 Adj. EPS $(0.06) Misses $(0.04) Estimate, Sales $18.40M Beat $16.11M Estimate   Benzinga
08:00AM EST  MannKind Corporation Reports 2020 Fourth Quarter and Full Year   GlobeNewswire Inc
04:03AM EST  Earnings Scheduled For February 25, 2021   Benzinga
Feb 24, 2021
08:02AM EST  Vertice Launches THYQUIDITY Oral Solution   RTTNews
08:01AM EST  Vertice launches THYQUIDITY(tm) (levothyroxine sodium) Oral Solution   PR Newswire
03:35AM EST  Earnings Scheduled For February 24, 2021   Benzinga
Feb 18, 2021
09:00AM EST  MannKind Corporation (NASDAQ:MNKD) will release its 2020 fourth quarter and full year financial results and its management will host a conference call to discuss the financial results and corporate updates at 9:00 AM (Eastern Time) on Thursday, February 25, 2021.   GlobeNewswire Inc
Feb 5, 2021
07:44AM EST  The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street   Benzinga
Feb 4, 2021
07:22AM EST  The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs   Benzinga
Jan 4, 2021
05:00PM EST  MannKind Corporation to Participate in H.C. Wainwright Bioconnect   GlobeNewswire Inc
Dec 18, 2020
07:48AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data   Benzinga
07:45AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data   Benzinga
Dec 17, 2020
04:47PM EST  Mannkind And Vertice To Co-Promote Thyquidity (Levothyroxine Sodium) Oral Solution, Mannkind's Sales Force Will Promote Thyquidity To Adult Endocrinologists, Pediatric Endocrinologists   Benzinga
04:44PM EST  MannKind and Vertice to Co-Promote   GlobeNewswire Inc
Dec 16, 2020
07:15AM EST  The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal   Benzinga
Dec 15, 2020
07:52AM EST  The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding   Benzinga
Dec 10, 2020
08:57AM EST  MannKind Corp. (MNKD) said that it appointed James Shannon as Chairman of the Board of Directors effective December 9, 2020.   RTTNews
08:15AM EST  MannKind Names James Shannon New Chairman Of The Board   RTTNews
08:00AM EST  MannKind Corporation (NasdaqMNKD) today announced that James S. Shannon, M.D., MRCP (UK) has been named the new Chairman of the Board of Directors effective December 9, 2020. Kent Kresa, the former Chairman of the Board, will continue to serve on MannKinds Board of Directors and as Chair of the Compensation Committee of the Board.   GlobeNewswire Inc
Dec 7, 2020
09:21AM EST  MannKind Acquires QrumPharma For $3.5M In Cash And 3,067,179 Shares Of MannKind Common Stock   Benzinga
09:20AM EST  MannKind Corporation(NasdaqMNKD) today announced that it has acquired QrumPharma, Inc., a privately held pharmaceutical company developing inhalation treatments for severe chronic and recurrent pulmonary infections, including Nontuberculous Mycobacterial (NTM) lung disease.   GlobeNewswire Inc
Dec 1, 2020
08:06AM EST  MannKind And MidCap Amend Credit Facility   Benzinga
08:00AM EST  -- $10 million funded immediately -- $25 million available upon TreT FDA approval -- Interest-only period extended to September 2022   GlobeNewswire Inc
Nov 30, 2020
08:00AM EST  Sabrina Kay Appointed to MannKind Board of Directors   GlobeNewswire Inc
Nov 20, 2020
08:06AM EST  The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger   Benzinga
Nov 19, 2020
05:01PM EST  MannKind Receives Fourth $12.5M Milestone Payment From United Therapeutics   Benzinga
05:00PM EST  MannKind Corporation(NASDAQ:MNKD) today announced that it has achieved the final development milestone under its licensing and collaboration agreement with United Therapeutics for the development and commercialization of a dry powder formulation of treprostinil.   GlobeNewswire Inc
Nov 13, 2020
07:40AM EST  The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations   Benzinga
Nov 12, 2020
08:43AM EST  Stocks Trading Near 52-Week Highs Before Open On Thursday, Nov. 12, 2020: NWSA, MNKD, NBACW, CELH, BIOC, DNLI, FIT, THCBW, PANL, PXS, AXTI, RH, THCB, PDD, UPWK, PLUG, UN, SING, PLTR   Benzinga
07:44AM EST  The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal   Benzinga
Nov 11, 2020
07:38AM EST  The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap   Benzinga
Nov 10, 2020
10:15AM EST  Corporation for Potential Breaches of Fiduciary Duty By Its Board of Directors   PR Newswire
Nov 4, 2020
04:02PM EST  MannKind Q3 EPS $(0.05), Inline, Sales $15.40M Miss $15.56M Estimate   Benzinga
04:00PM EST  MannKind Corporation Reports 2020 Third Quarter Financial Results   GlobeNewswire Inc
08:21AM EST  The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings   Benzinga
04:41AM EST  Earnings Scheduled For November 4, 2020   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 29, 2020
08:00AM EDT  MannKind Corporation (NASDAQ:MNKD) will release its 2020 third quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, November 4, 2020.   GlobeNewswire Inc
Sep 8, 2020
08:00AM EDT  MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases, announced today that it will be participating at upcoming conferences. Presenting from the Company will be its Chief Executive Officer, Michael Castagna, PharmD.   GlobeNewswire Inc
Aug 31, 2020
09:00AM EDT  Kevin Kaiserman Joins MannKind as Vice President, Medical Affairs   GlobeNewswire Inc
Aug 7, 2020
05:00PM EDT  MannKind Corporation to Participate in BTIG Virtual Biotechnology   GlobeNewswire Inc
Aug 6, 2020
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
Aug 5, 2020
04:01PM EDT  MannKind Q2 EPS $(0.05), Inline, Sales $15.11M Beat $14.76M Estimate   Benzinga
04:00PM EDT  -- 2Q 2020 Afrezza Net Revenue of $7.0 million; +15% vs. 2Q 2019 -- 1H 2020 Afrezza Net Revenue of $15.0 million; +35% vs. 1H 2019 -- Cash and cash equivalents of $63.2 million at June 30, 2020 -- Non-GAAP cash used in operating activities decreased by 37% vs. 1H 2019 -- Chief Commercial Officer, Alejandro Galindo, joined MannKind   GlobeNewswire Inc
04:21AM EDT  Earnings Scheduled For August 5, 2020   Benzinga
Jul 20, 2020
09:24AM EDT  MannKind Names Alejandro Galindo Chief Commercial Officer   RTTNews
09:14AM EDT  Alejandro Galindo Joins MannKind As Chief Commercial Officer   Benzinga
09:00AM EDT  MannKind Corporation (NASDAQ: MNKD) today announced that effective August 4, 2020, Alejandro Galindo, M.B.A, M.S., will be leading MannKinds commercial operations as Chief Commercial Officer. Mr. Galindo will report directly to Michael Castagna, Chief Executive Officer and will serve on the companys executive leadership team.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC